DAA	Direct Antiviral Agents
HCC	Hepatocellular carcinoma
HCV	Hepatitis C virus
BCLC	Barcelona Clinic Liver Cancer
NAFLD	non-alcoholic fatty liver disease
HCV	Hepatitis C virus
SVR	sustained virological response
NK	Natural Killer
IFN	Interferon
TNF-α	Tumor necrosis factor-α
MAIT	mucosal-associated invariant T cell
SOF	sofosbuvir
SOF/VEL	sofosbuvir/velpatasvir
SOF/RBV	sofosbuvir/ribavirin
SOF/LDV	sofosbuvir/ledipasvir
SOF/DCV	sofosbuvir/daclatasvir
SOF/SMV	sofosbuvir/simeprevir
3D	ombitasvir/paritaprevir/ritonavir + dasabuvir
RBV	ribavirin
EBR/GZR	elbasvir/grazoprevir
GLE/PIB	glecaprevir/pibrentasvir
AFP	alpha-fetoprotein levels
PIVKA	prothrombin induced by vitamin K absence
CT	Computed tomography
MRI	Magnetic Resonance Imaging
TACE	transarterial Chemoembolization
RFA	radiofrequency ablation
EASL	European Association for the Study of the Liver
AGA	American Gastroenterological Association